SAFLINK Partners with Documentum to Develop Pharmaceutical Document Life Cycle Security

BELLEVUE, Wash.--(BUSINESS WIRE)--March 15, 2004--

Integrated Webtop Components to Assist Pharmaceutical Firms in Boosting Document Security to Meet Federal Compliance Requirements

“In teaming with one of the industry's most respected ECM providers, we believe we can provide the level of security required in one of today's most heavily regulated industries -- both economically and efficiently.”

SAFLINK(R) Corporation (Nasdaq:SFLK), a leading developer, marketer, and integrator of biometric security solutions, announced today that it is partnering with Documentum to develop secure Webtop components targeted at meeting the security needs of the pharmaceutical industry. Documentum, a division of EMC Corporation, is a leading provider of enterprise content management (ECM) solutions for some of the world's largest companies, with products that address compliance goals, drive down operational costs, and reduce the risk of non-compliance for pharmaceutical firms. Documentum currently names 49 of the top 50 worldwide pharmaceutical firms as customers.

As a Documentum technology partner, SAFLINK plans to develop a collection of components for secure authentication that are designed to be integrated into Documentum's browser-based content management services.

"Our past experience with pharmaceutical firms has shown that SAFLINK's authentication products can not only resolve the management headaches of traditional passwords, but they can also deliver an almost immediate return on investment by dramatically reducing the time required to digitally sign a document or action," said Cliff Kittle, Director of Emerging Markets for SAFLINK. "In teaming with one of the industry's most respected ECM providers, we believe we can provide the level of security required in one of today's most heavily regulated industries -- both economically and efficiently."

SAFLINK intends to develop Documentum Webtop components through its SAFauthenticator(TM) Software Development Kit (SDK) to add a Secure Authentication Framework (SAF) to Documentum's enterprise applications. Through the use of biometrics, this framework is designed to guarantee the identity of a person participating in the creation and management of critical business documents, and to provide the level of irrefutable identification required in many highly regulated industries.

Once in place, SAFLINK's solution simplifies and strengthens system logon procedures by replacing a user's passwords with a unique individual characteristic, such as a fingerprint or iris scan. This type of authentication controls and documents the identities of users accessing business information, signing an action, or using an application.

About SAFLINK

SAFLINK Corporation offers software solutions designed to protect intellectual property, secure information assets, and eliminate passwords. SAFLINK's software provides Identity Assurance Management(TM), allowing administrators to verify the identity of users and control their access to: computer networks; physical facilities; applications; manufacturing process control systems; and time and attendance systems. For more information, please see www.saflink.com or call 800-762-9595.

NOTE: "SAFLINK" is a registered trademarks of SAFLINK Corporation. "SAFmodule" and "Protecting your enterprise through secure authentication" are trademarks of SAFLINK Corporation.

This release contains information about management's view of the company's future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with the amount and nature of business opportunities that may be presented to the company, the introduction or change of various laws or regulations, including those related to the pharmaceutical industry, the company's financial condition, its ability to sell its products, its ability to react to increasing competition from other biometric security solution providers or other technologies, and the growth of the biometric security market as well as other factors that are discussed in the company's 424(b)(3) Prospectus filed with the SEC August 16, 2002 as amended and supplemented, and in its Annual Report on Form 10-K, as well as other documents periodically filed with the Securities and Exchange Commission.